Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Primecap Odyssey Aggressive Growth Fund (POAGX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.10 -0.21    -0.50%
18/04 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Fund
Market:  United States
Issuer:  PRIMECAP Odyssey Funds
Underlying:  S&P 500 TR
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 7.21B
PRIMECAP Odyssey Aggressive Growth 42.10 -0.21 -0.50%

POAGX Overview

 
Find basic information about the Primecap Odyssey Aggressive Growth Fund mutual fund such as total assets, risk rating, Min. investment, market cap and category. Learn about the fund's agencies rating and risk rating, transparent information about the fund's management personal, policies of invested allocation and diversification, past performance. In addition we provide you related news, analysis tools, interactive charts and analysis articles. You may add POAGX MF to your portfolio and watchlist to keep track with the fund's performance and users commentary.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Rating
1-Year Change6.01%
Prev. Close42.31
Risk Rating
TTM Yield0.02%
ROE9.84%
IssuerPRIMECAP Odyssey Funds
Turnover5%
ROA1.26%
Inception DateNov 01, 2004
Total Assets7.21B
Expenses0.65%
Min. Investment2,000
Market Cap25.67B
CategoryMid - Cap Growth
What is your sentiment on PRIMECAP Odyssey Aggressive Growth?
or
Vote to see community's results!

Primecap Odyssey Aggressive Growth Fund News


FDA approves Takeda's ENTYVIO for Crohn's disease
FDA approves Takeda's ENTYVIO for Crohn's disease By Investing.com - 3 hours ago

OSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company (NYSE:TAK) Limited (TSE:4502/NYSE:TAK) has received approval from the U.S. Food and Drug Administration (FDA) for...

IDACORP announces $0.83 per share dividend for May
IDACORP announces $0.83 per share dividend for May By Investing.com - 5 hours ago

BOISE, Idaho - IDACORP, Inc. (NYSE:IDA), an Idaho-based electric utility company, has announced the declaration of a quarterly dividend. The company's board of directors has...

Primecap Odyssey Aggressive Growth Fund Analysis


Performance

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

YTD 3M 1Y 3Y 5Y 10Y
Growth of 1000 1047 1047 1182 1024 1515 2802
Fund Return 4.66% 4.66% 18.2% 0.78% 8.66% 10.85%
Place in category 514 514 437 315 381 130
% in Category 91 91 78 64 81 33

Top Equity Funds by PRIMECAP Odyssey Funds

  Name Rating Total Assets YTD% 3Y% 10Y%
  PRIMECAP Odyssey Growth 6.28B 5.88 6.15 11.82
  PRIMECAP Odyssey Stock 5.57B 9.86 9.52 11.93

Top Funds for Mid-Cap Growth Category

  Name Rating Total Assets YTD% 3Y% 10Y%
  T. Rowe Price Mid-Cap Growth I 13.26B 8.50 4.20 -
  T. Rowe Price Mid-Cap Growth 13.12B 8.47 4.07 11.20
  T. Rowe Price New Horizons I 12.31B 6.12 -3.10 -
  Principal MidCap Institutional 12.26B 10.97 9.12 12.70
  Vanguard Mid-Cap Growth Index Admir 11.87B 7.56 3.89 10.63

Top Holdings

Name ISIN Weight % Last Change %
  Eli Lilly US5324571083 4.90 745.95 -0.64%
Splunk Inc US8486371045 3.61 - -
  Micron US5951121038 3.51 111.93 -3.78%
  Rhythm Pharma US76243J1051 3.30 38.08 -0.96%
  Biogen US09062X1037 3.16 190.52 -0.85%

Technical Summary

Type Daily Weekly Monthly
Moving Averages Strong Sell Strong Sell Sell
Technical Indicators Strong Sell Sell Strong Buy
Summary Strong Sell Strong Sell Neutral
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

POAGX Comments

Write your thoughts about Primecap Odyssey Aggressive Growth Fund
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email